Advances in the prevention and management of preeclampsia. Systematic review [Avances en la prevención y manejo de la Preeclampsia. Revisión sistemática]
DOI:
https://doi.org/10.62574/53rcdq49Keywords:
pre-eclampsia, obstetric labor complications, maternal deathAbstract
Objective: to analyse the use of Cinacalcet for the treatment of secondary hyperparathyroidism. Method: Systematic review. Results and conclusion: to analyse advances in the prevention and management of preeclampsia. Method: Systematic review. Results and conclusion: Recent advances in the prevention and management of preeclampsia have led to a better understanding of its pathophysiology and the implementation of more effective strategies, such as the use of low-dose acetylsalicylic acid, early screening using biomarkers and uterine artery Doppler, and the exploration of emerging therapies such as statins. However, challenges remain in relation to the personalisation of interventions, the identification of preconception risk factors and the optimisation of management in specific clinical scenarios, such as caesarean delivery.
Downloads
References
Lin L, Huai J, Li B, et al. A randomized controlled trial of low-dose aspirin for the prevention of preeclampsia in women at high risk in China. Am J Obstet Gynecol. 2022;226(2):251.e1-251.e12. doi:10.1016/j.ajog.2021.08.004
Huai J, Lin L, Juan J, et al. Preventive effect of aspirin on preeclampsia in high-risk pregnant women with stage 1 hypertension. J Clin Hypertens (Greenwich). 2021;23(5):1060-1067. doi:10.1111/jch.14149
Mendoza M, Bonacina E, Garcia-Manau P, et al. Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical Trial. JAMA. 2023;329(7):542-550. doi:10.1001/jama.2023.0691
Nguyen-Hoang L, Dinh LT, Tai AST, et al. Implementation of First-Trimester Screening and Prevention of Preeclampsia: A Stepped Wedge Cluster-Randomized Trial in Asia. Circulation. 2024;150(16):1223-1235. doi:10.1161/CIRCULATIONAHA.124.069907
Diguisto C, Le Gouge A, Marchand MS, et al. Low-dose aspirin to prevent preeclampsia and growth restriction in nulliparous women identified by uterine artery Doppler as at high risk of preeclampsia: A double blinded randomized placebo-controlled trial. PLoS One. 2022;17(10):e0275129. Published 2022 Oct 19. doi:10.1371/journal.pone.0275129
Tolcher MC, Sangi-Haghpeykar H, Mendez-Figueroa H, Aagaard KM. Low-dose aspirin for preeclampsia prevention: efficacy by ethnicity and race. Am J Obstet Gynecol MFM. 2020;2(4):100184. doi:10.1016/j.ajogmf.2020.100184
S D, Novri DA, Hamidy Y, Savira M. Effectiveness of nifedipine, labetalol, and hydralazine as emergency antihypertension in severe preeclampsia: a randomized control trial. F1000Res. 2023;11:1287. Published 2023 Apr 27. doi:10.12688/f1000research.125944.2
Guo L, Qin R, Ren X, et al. Prophylactic norepinephrine or phenylephrine infusion for bradycardia and post-spinal anaesthesia hypotension in patients with preeclampsia during Caesarean delivery: a randomised controlled trial. Br J Anaesth. 2022;128(5):e305-e307. doi:10.1016/j.bja.2022.01.027
Nobles CJ, Mendola P, Mumford SL, et al. Preconception Blood Pressure and Its Change Into Early Pregnancy: Early Risk Factors for Preeclampsia and Gestational Hypertension. Hypertension. 2020;76(3):922-929. doi:10.1161/HYPERTENSIONAHA.120.14875
Costantine MM, Lawrence-Cleary K, Saade G, Wapner RJ. Letter by Costantine et al Regarding Article, "Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia". Circulation. 2022;145(4):e115-e116. doi:10.1161/CIRCULATIONAHA.121.056728
Wei J, Liao JK, Bairey Merz CN. Challenging Statin Pleiotropy: Preeclampsia. Circulation. 2021;144(9):680-683. doi:10.1161/CIRCULATIONAHA.121.056140
Döbert M, Varouxaki AN, Mu AC, et al. Pravastatin Versus Placebo in Pregnancies at High Risk of Term Preeclampsia. Circulation. 2021;144(9):670-679. doi:10.1161/CIRCULATIONAHA.121.053963
Lin XM, Li DZ. Prevention of recurrent preeclampsia in high-risk pregnancies: Is it time for a paradigm shift?. Am J Obstet Gynecol. 2023;229(2):187-188. doi:10.1016/j.ajog.2023.03.035
Costantine MM, Clifton RG, Saade GR. Reply: Investigations of pravastatin for the prevention of preeclampsia. Am J Obstet Gynecol. 2023;229(2):188-189. doi:10.1016/j.ajog.2023.03.036
Gajzlerska-Majewska W, Bomba-Opon DA, Wielgos M. Is pravastatin a milestone in the prevention and treatment of preeclampsia?. J Perinat Med. 2018;46(8):825-831. doi:10.1515/jpm-2017-0109
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Dayana Andrea Aizprua-Marcillo, Camila Nicol López-Haro, Karen Mishell Nenger-Sánchez, Silvia del Pilar Nuñez-Arroba
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
